523 related articles for article (PubMed ID: 27487829)
1. Progression of Metabolic Syndrome Severity During the Menopausal Transition.
Gurka MJ; Vishnu A; Santen RJ; DeBoer MD
J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27487829
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome and its components in premenopausal and postmenopausal women: a comprehensive systematic review and meta-analysis on observational studies.
Hallajzadeh J; Khoramdad M; Izadi N; Karamzad N; Almasi-Hashiani A; Ayubi E; Qorbani M; Pakzad R; Hasanzadeh A; Sullman MJM; Safiri S
Menopause; 2018 Oct; 25(10):1155-1164. PubMed ID: 29787477
[TBL] [Abstract][Full Text] [Related]
3. Smoking status, the menopausal transition, and metabolic syndrome in women.
Kwaśniewska M; Pikala M; Kaczmarczyk-Chałas K; Piwonńska A; Tykarski A; Kozakiewicz K; Pająk A; Zdrojewski T; Drygas W
Menopause; 2012 Feb; 19(2):194-201. PubMed ID: 22011755
[TBL] [Abstract][Full Text] [Related]
4. The relationship between menopausal symptoms and metabolic syndrome in postmenopausal women.
Cengiz H; Kaya C; Suzen Caypinar S; Alay I
J Obstet Gynaecol; 2019 May; 39(4):529-533. PubMed ID: 30744450
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of metabolic syndrome in pre- and postmenopausal Iranian women.
Maharlouei N; Bellissimo N; Ahmadi SM; Lankarani KB
Climacteric; 2013 Oct; 16(5):561-7. PubMed ID: 23157491
[TBL] [Abstract][Full Text] [Related]
6. Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women.
Matthews KA; Wing RR; Kuller LH; Meilahn EN; Plantinga P
Arch Intern Med; 1994 Oct; 154(20):2349-55. PubMed ID: 7944857
[TBL] [Abstract][Full Text] [Related]
7. Association between menopausal symptoms and metabolic syndrome in postmenopausal women.
Lee SW; Jo HH; Kim MR; Kwon DJ; You YO; Kim JH
Arch Gynecol Obstet; 2012 Feb; 285(2):541-8. PubMed ID: 21853251
[TBL] [Abstract][Full Text] [Related]
8. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
9. Association between salivary pH and metabolic syndrome in women: a cross-sectional study.
Tremblay M; Brisson D; Gaudet D
BMC Oral Health; 2012 Sep; 12():40. PubMed ID: 22958748
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and predictors of metabolic syndrome among Congolese pre- and postmenopausal women.
Muchanga Sifa MJ; Lepira FB; Longo AL; Sumaili EK; Makulo JR; Mbelambela EP; Tozin R; Ngatu NR; Suganuma N
Climacteric; 2014 Aug; 17(4):442-8. PubMed ID: 24156784
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the presence and severity of menopausal symptoms among postmenopausal women screened for the metabolic syndrome.
Chedraui P; Pérez-López FR; Hidalgo L; Villacreses D; Domínguez A; Escobar GS; Genazzani AR; Simoncini T;
Gynecol Endocrinol; 2014; 30(12):918-24. PubMed ID: 25347000
[TBL] [Abstract][Full Text] [Related]
12. The effect of menopause on metabolic syndrome: cross-sectional results from the Canadian Longitudinal Study on Aging.
Christakis MK; Hasan H; De Souza LR; Shirreff L
Menopause; 2020 Sep; 27(9):999-1009. PubMed ID: 32852451
[TBL] [Abstract][Full Text] [Related]
13. Associations of follicle-stimulating hormone and luteinizing hormone with metabolic syndrome during the menopausal transition from the National Health and Nutrition Examination Survey.
Chen Y; Wang C; Sun B; Wang B; Lu X; Gao B; Cao Y; Zhou J; Liu X
Front Endocrinol (Lausanne); 2023; 14():1034934. PubMed ID: 36843613
[TBL] [Abstract][Full Text] [Related]
14. Association of the Number of Years Since Menopause with Metabolic Syndrome and Insulin Resistance in Chinese Urban Women.
Yan F; Liu J; Zhao X; Hu X; Wang S; Ma Z; Liang K; Song J; Wang C; Hou X; Chen S; Chen L
J Womens Health (Larchmt); 2015 Oct; 24(10):843-8. PubMed ID: 26418517
[TBL] [Abstract][Full Text] [Related]
15. Metabolic implications of menopause.
Polotsky HN; Polotsky AJ
Semin Reprod Med; 2010 Sep; 28(5):426-34. PubMed ID: 20865657
[TBL] [Abstract][Full Text] [Related]
16. Role of social determinants and lifestyle on women's metabolic risk during the perimenopausal transition: results from a cohort study.
Kim S; Ko Y; Yi G
Menopause; 2016 Apr; 23(4):403-9. PubMed ID: 26671189
[TBL] [Abstract][Full Text] [Related]
17. Effects of high-intensity training on cardiovascular risk factors in premenopausal and postmenopausal women.
Mandrup CM; Egelund J; Nyberg M; Lundberg Slingsby MH; Andersen CB; Løgstrup S; Bangsbo J; Suetta C; Stallknecht B; Hellsten Y
Am J Obstet Gynecol; 2017 Apr; 216(4):384.e1-384.e11. PubMed ID: 28024987
[TBL] [Abstract][Full Text] [Related]
18. [Study on risk factors of cardiovascular disease and the status of bone mineral density in women with hypoestrogenism].
Zhao F; Guo XT; Cheng Y; Yang ZF; Liu HP
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):734-9. PubMed ID: 24406128
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and severity of menopause symptoms among perimenopausal and postmenopausal women aged 30-49 years in Gulele sub-city of Addis Ababa, Ethiopia.
Yisma E; Eshetu N; Ly S; Dessalegn B
BMC Womens Health; 2017 Dec; 17(1):124. PubMed ID: 29216870
[TBL] [Abstract][Full Text] [Related]
20. Obesity and metabolic syndrome during the menopause transition in Serbian women.
Zivkovic TB; Vuksanovic M; Jelic MA; Stojanovic J; Buric B; Jojic B; Milic N; Vujovic S
Climacteric; 2011 Dec; 14(6):643-8. PubMed ID: 21878054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
